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Abstract 
T cells acquire various proteins from their cellular partners by the process of trogocytosis. We 
recently demonstrated that the FcγRIIIA receptor and its associated FcRγ are captured by T 
cells during their co-culture with FcγR-expressing target cells upon both antigen- or antibody-
mediated stimulation. Interestingly, we found that FcR captured by T cells could bind ligands 
but did not transmit detectable intracellular signals or signaling-depending functions upon 
ligand binding suggesting their improper integration in the recipient T cell membrane. In this 
study, we provide morphological data in support of this hypothesis. Indeed, we show that the 
FcRγ-subunit, which we used as a fusion to GFP, was clearly present at the plasma membrane 
of donor cells, but was detected within structures that were in close contact of, but apparently 
not integrated in, the plasma membrane of recipient T cells.
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Introduction 
Trogocytosis refers to the process whereby most hematopoietic cells capture fragments of the 
plasma membrane of the cells with which they interact. This is particularly the case for T 
cells, which perform trogocytosis upon recognition of their cognate antigen on antigen-
presenting cells (APC). Consequently, T cells harbor on their surface not only the antigen but 
also a series of molecules that they do not synthesize themselves. Many different roles have 
been proposed for trogocytosis in T cell biology but their physiological relevance and 
underlying mechanisms have not been demonstrated (1-4). Most of the functions of 
trogocytosis identified so far require that molecules captured by T cells interact with their 
ligand on the same or different cells without the need for intracellular signalling events. For 
instance, capture by T cells of the antigen and of co-stimulatory molecules followed by 
interaction with the TCR and CD28 on other T cells results in T cell-T cell interactions 
leading to activation, tolerance or exhaustion (4). The transfer of several receptors by 
trogocytosis has been reported on T cells (5-7), B cells (8) or NK cells for instance (9-12) but 
it is unclear whether they could insert properly in the T cell membrane and transmit 
intracellular signals similar to those elicited in the presenting cell, naturally expressing these 
molecules. We recently showed that Fc receptors (FcR) as well as the associated FcRγ subunit 
could be detected at high levels on murine and human T cells after their intercellular transfer 
from FcγR-expressing APC (13). Capture of FcγR occurred during co-culture of T cells with 
FcγR-expressing APC both upon antibody (Ab)- or antigen-mediated T cell stimulation. Once 
captured by T cells, FcγR were displayed in a conformation compatible with physiological 
function and conferred upon T cells the ability to bind immune complexes, as well as to 
provision B cells with this source of antigen. However, we could not detect downstream 
signals or signaling-dependent functions following triggering of FcγR captured by T cells. In 
addition, biochemical studies suggested the improper integration of FcγR in the recipient T 
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cell membrane (13). However, we had no morphological evidence supporting this notion. In 
this study, we analyzed the location of FcγR on APC and on T cells having captured these 
receptors by trogocytosis. 
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Material and Methods 
 
Cell lines and mice. The HEK 293 cell line transfectant expressing FcγRIIIA + FcRγGFP were 
used as target cells. The CD8+ T cells specific for OVA peptide 257-264 (SIINFEKL) 
presented by the H-2Kb MHC class I molecules were obtained from the OT-I TCR-transgenic 
mice (Charles River, LeGenest, France) (14). Total splenocytes from OT-I mice were cultured 
in the presence of 0.1 µM of the appropriate antigenic peptide and used in trogocytosis or 
functional assays 4 to 6 days after stimulation.  
 
Reagents, antibodies and molecular biology. Fluorescently labelled monoclonal antibodies 
(mAb) against mouse CD8α (53.6.7.2) and FcγRIIB/FcγRIIIA (2.4G2) and streptavidin were 
from Becton-Dickinson/Pharmingen (Le-Pont-de-Claix, France). Unlabeled mAb to H-2Kb 
(Y3) was purified from culture supernatant of the corresponding hybridoma. Ab to GFP were 
from Abcam (Paris, France).  
 
Trogocytosis. HEK expressing a flagged form of FcγRIIIA (15) + FcRγGFP cells (13) were 
incubated in T175 culture flasks (25-30x106cells/flask) with T cells (10x106cells/flask in 10 
ml final volume) for 1 hour at 37°C. T cells were previously incubated or not with 5 µg/ml of 
the anti-H-2Kb mAbs for 30 minutes at 4°C. T cells were then analyzed by flow cytometry on 
a FACSCalibur or LSRII (Becton Dickinson) using anti-CD8 or anti-CD4 mAb. Staining with 
anti-FcγR and detection of GFP fluorescence was used to detect trogocytosis.  
 
Immuno-electron microscopy. Cells were fixed for 1 hour with 4% formaldehyde (EMS, 
Delta-Microscopies, France) in buffer A (0.1 M cacodylate buffer, pH 7.2, containing 0.1 M 
sucrose, 5mM CaCl2 and 5 mM MgCl2) at room temperature, washed 3 times in the same 
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buffer and treated with 50 mM ammonium chloride for 30 minutes. Cells were then 
concentrated in 2% Agar in buffer A. After Agar concentration, cells were infused in high 
concentrations of sucrose before being frozen in liquid nitrogen. Frozen samples were then 
substituted in 0.5% uranyl acetate in methanol at -90°C in a cryosubstitution apparatus (AFS, 
Leica Microsystems). Then infiltrations and embedding.in Lowicryl HM20 were performed at 
-45°C and the Lowicryl resin was polymerised with UV light. 
Then ultra-thin sections were performed on a Leica Ultracut microtome and were mounted on 
Formvar-carbon-coated 200 mesh nickel grids. After 15 minutes on a drop of PBS (pH 7.6), 
the sections were quenched in 0.05 M glycine in PBS and incubated in blocking solution 
(PBS+5%BSA) for 30 minutes (all from Aurion, Delta-Microscopies, France) followed by 
anti-GFP primary Abs (Abcam) diluted in PBS-1% BSA for 2 hours at room temperature. The 
sections were washed for 30 minutes with PBS containing 1% BSA and incubated for 1 hour 
with goat anti-rabbit IgGs conjugated to 10 nm colloidal gold particles (BioValley, Marne-La-
Vallée, France) in PBS containing 1% BSA. The grids were then washed for 20 minutes in 
PBS, fixed for 5 minutes with 1% glutaraldehyde in PBS and rinsed in distilled water. Finally, 
thin sections were stained with 1% uranyl acetate and lead citrate and examined at 80 kV on a 
Jeol 1200-EX electron microscope at the IFR 109 electron microscopy facility. 
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Results 
 
OT-I CD8+ T cells acquire murine FcRγGFP upon co-culture with FcγRIIIA/ FcRγGFP -
expressing HEK cells. We recently showed that FcγRIIB/IIIA as well as the FcRγ subunit 
could be captured by trogocytosis triggered in T cells by mAb such as the anti-H-2Kb mAb or 
by antigen (13). In order to obtain a large number of T cells having acquired FcγR during 
trogocytosis we tested if FcγR capture could be detected in trogocytosis experiments 
performed in large T175 culture flasks. As shown in Fig. 1, we found that, in these 
experimental conditions as well, OT-I CD8+ T cells captured FcγRIIIA from HEK cells 
transfected with cDNA encoding murine FcγRIIIA plus the FcRγGFP subunit (also called 
FcεRIγ or γ) when co-cultured in the presence of the anti-H-2Kb mAb. Capture of FcγRIIIA 
was detected using anti-FcγRIIB/IIIA mAb (Fig. 1A) and capture of the FcRγGFP subunit (Fig. 
1B) was determined using GFP fluorescence. This material was then used in electron 
microscopy experiments in order to visualize the localization of these molecules on donor 
APC and on recipient T cells. Note that most HEK cells remained adhered when T cells were 
harvested explaining why so few cells appear in the lower panels. Furthermore, using LSR-II 
flow cytometer, we found it very difficult to have both T cells and HEK cells in the same 
FSC/SSC dot plots. As our study was focused on T cells, most HEK cells present in the 
sample were not present in the SSC/FSC gating we used, centered on T cells. Therefore, the 
cells appearing in the lower panels are not only very few and, in addition, they are not 
representative in terms of the fluorescent signals recorded on the whole HEK cell population. 
 
Donor HEK cells and recipient OT-I T cells can be easily distinguished based on 
morphology. As we wanted to analyze the localization of FcR on a two-partner cell culture, 
we first determined if staining with specific Abs was necessary to distinguish OT-I T cells 
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from HEK cells or if morphological parameters were sufficient. As shown in two examples 
provided in Fig. 2, donor HEK cells and recipient T cells can unambiguously be identified 
based on morphological features. First, HEK cells are much larger (size) than OT-I T cells 
(size). Second the cytoplasm of HEK cells appears as very light as compared to that of OT-I T 
cells, including much larger size and weaker electronic density of the cytoplasm for HEK. 
Therefore one can easily analyze either OT-I T cells or HEK cells without performing cell-
specific staining with Ab. 
 
FcRγGFP captured by T cells exhibit different localizations as compared to FcγR 
endogenously expressed by target cells. Next we examined the localization of FcRγ by 
immuno-electron microscopy in both donor cells (expressing this molecule endogenously) 
and recipient T cells (expressing it after capture). We did not manage to perform these 
experiments using the 2.4G2 mAb specific for FcγRIIB/IIIA. However, a previous work 
having validated the use of polyclonal rabbit anti-GFP Ab in electron microscopy 
experiments (16), we analyzed the localization of FcRγGFP, using this antibody when cells 
were detected using gold-labeled anti-rabbit antiserum. Figure 3 shows a collection of images 
showing that FcRγGFP was clearly present at the plasma membrane as well as in intracellular 
compartments of donor HEK-FcγRIIIA-FcRγGFP transfectants. In particular it was present in 
structures resembling microvilli. However, in T cells having captured FcRγGFP, we detected 
the molecule within structures of heterogeneous size that were in close contact but apparently 
not integrated in the T cell membrane (Fig. 4). When looking at the area of contact between 
HEK transfectants and T cells, FcRγGFP  are clearly detectable in the plasma membrane of 
HEK cells, while in T cells FcRγGFP was present in vesicular or tubular structures closely 
apposed to but not inserted into the T cell membrane (Fig. 5, 6 and 7). Altogether our results 
are suggestive of an improper integration of FcRγGFP in the plasma membrane of T cells. 
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Discussion 
 
Although the transfer of proteins between immune cells has been anecdotically reported for 
years, the widespread nature of this phenomenon and its potential biological significance has 
only been described recently. Indeed, protein transfer, and in particular trogocytosis, has been 
proposed to play a role in fundamental processes such as the initiation and regulation of 
immune responses (1, 3). Thus, it is critical to identify molecules that can be captured by 
immune cells, to understand the molecular basis of the transfer and most importantly, to 
define the function of captured molecules on recipient cells.  
Previously, we showed that T cells efficiently acquired FcγR from APC both during 
antibody- or antigen-mediated stimulation and displayed them in a correct orientation and 
topology on their surface (13). After capture of FcγR, T cells could bind FcγR ligands very 
efficiently, while no detectable biochemical or functional response resulted from this binding. 
Furthermore, we found indications that uncoupling between ligand binding and functional 
response upon stimulation of FcγR acquired by T cells could be due to a different behavior of 
FcγR captured by T cells as compared with receptors endogenously expressed by donor cells 
that was probably resulting from the incomplete integration of captured FcγR into the T cell 
membrane (13). Note that, even if they were not capable of transmitting intercellular signals, 
captured receptors could nevertheless confer on recipient cells new functions that solely 
require their ability to bind ligands (13). In the current study, we provide morphological data 
supporting this conclusion by showing that molecules of the FcR complex do not appear to be 
properly integrated in the membrane of recipient T cells while it is the case in donor, 
presenting cells.  
Our data support a model whereby captured FcR molecules could be present in 
structures attached, but not integrated, to the membrane of the recipient T cells. This would 
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explain why, being well orientated FcR, they can still bind extracellular ligands but do not 
propagate signals inside the T cell (13). Our observations also explain why materials captured 
by trogocytosis can be, at least partly, removed after treatment with low pH solution (9, 11, 
13). Very few morphological analyses of the process of trogocytosis by electron microscopy 
are available (9, 16, 17, 18). We believe that the images we obtained on the localization of the 
FcRγGFP subunit resemble those published earlier where captured molecules were found 
within membranous structures loosely attached to the plasma membrane of NK cells (9) or T 
cells (17). In another study, heterogeneous materials (compatible with the involvement of 
both exosomes and shed membranes) were also found to be apposed but not integrated in the 
recipient T cells membrane (18). However, as this was analyzed at late time points (24 hours) 
of the co-culture, it is unclear whether this transfer is related to trogocytosis or not (18). It is 
also unclear if the data provided by Pardigon and Yewdell regarding the capture of TL by 
CD8αα T cells support a model whereby TL would be properly integrated or not in the 
recipient T cell membrane (16). However their data clearly indicate that the molecules 
captured are present within structures much larger than exosomes and not diffuse in the T cell 
membrane (16). Fluorescent microscopy analyses performed in various experimental systems 
also revealed that molecules, once captured, do not freely diffuse in the recipient cell 
membrane but are retained in discrete domains (9, 10, 16, 19-22). Limited information is 
available regarding the ability of receptors captured by trogocytosis to transmit intracellular 
signals in recipient cells and to confer on these cells novel functions depending on signaling. 
For instance, NK cells have been shown to capture receptors for Epstein-Barr virus 
(CD21)(12) or for poliovirus (CD155) (23). However, this did not apparently sensitize NK 
cells to virus infection as shown in the first study in which this possibility was examined (12). 
However the interpretation of these data is complicated by the fact that the absence of 
detectable infection in these cells could be the result of more complex events, such as the 
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inability of the virus to replicate within these cells, or reduction of the viral load to 
undetectable levels due to the production of anti-viral molecules by the NK cell. The group of 
Parish in Canberra reported that, unlike the endogenously expressed BCRs, those captured by 
B cells do not transmit intracellular calcium fluxes upon stimulation (8). This is very much in 
line with our report on FcR (13). Furthermore Patel et al have found that MHC class II 
molecules captured by T cells do not sensitize these cells to complement-mediated killing in 
the presence of anti-MHC class II Ab, while donor cells were lyzed by the same treatment 
(17). These data are in favor of a model whereby molecules  acquired by trogocytosis could 
be present in membrane structures adsorbed or apposed to recipient cell membrane but not 
fusing with those latter. However a recent publication by the group of Parish now reports that 
T cells having captured TCR from other T cells could kill target cells expressing the antigen 
recognized by the acquired TCR (6). Although the integration of the acquired TCR and its 
signaling properties have not been investigated in the recipient T cell themselves, these results 
suggest that acquired TCR could be functional after capture and thus could be well integrated. 
More complex scenarios could however account for this observation as improperly-integrated, 
captured TCR could be co-down-modulated with properly-integrated, endogenously 
expressed TCR to induce signaling (24, 25). Note that the study by Chaudhri et al (6) differs 
from many others in that activated T cell do give materials (TCR) to neighboring cells rather 
than acquiring molecules from those (see (2) and references therein). Thus this study appears 
to be more in line with the observation that activated T cells release their TCR in an exosome-
associated form (26). Whatever these differences, it remains to be determined why related 
processes of intercellular transfer of molecules in a membrane-bound form could result in 
integration or not of the captured molecules in the recipient cell membrane, depending on the 
nature of the recipient cell. 
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Apart from purely methodological explanations, we perceive that there are several 
possible mechanistic explanations to understand the differences between the apparent 
discrepancies resulting from the studies discussed above. First, it is possible that the detection 
level of the function examined by Parish et al is so low that even a very low number of 
acquired TCR that integrate properly is sufficient to confer function on recipient T cells (6). 
Indeed it is well known that CTL cytotoxicity is a very sensitive function (27, 28) and that as 
few as 500-1000 TCR could be sufficient to activate T cells (29). However, although direct 
comparison is not possible, other very sensitive functions, i.e. complement-mediated killing 
and antibody-dependent cell cytotoxicity, have also been used both in the study by Patel et al 
(17) and in our study (13), but remained undetectable after triggering of acquired receptors.  
Another possibility is that membrane structures conveying the receptor have different 
fusogenic properties. For instance it is still unknown if, during trogocytosis, intercellular 
transfer of molecules is mediated by exosomes, microparticules, nanotubes, membrane 
bridges or patches of torn membranes (1). Possibly, depending on the mechanisms involved, 
this could result in, no, little or even full integration of the acquired molecule. In the absence 
of molecular tools to selectively block these different processes, it is still impossible to 
answer this question. If some donor cells are more prone than others to give membrane 
materials using one of these mechanisms, and if recipient cells have differential abilities to 
integrate these structures, one can predict that the nature of the cell partners present in the 
coculture is a critical parameter.  
Note that evidence for the transfer of receptors remaining functional in tumor cell lines 
could be due to different mechanisms, and that tumor cells and not normal cells were used 
(30). More examples reporting on the functionality of acquired receptors will be helpful to 
understand the consequences of trogocytosis in T cell biology and further advance the two 
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major questions concerning the mechanisms of trogocytosis, e.g. the molecular basis of 
protein transfer and the functional properties of captured molecules.  
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Legend to Figures. 
 
 
Figure 1. Both FcγRIII and FcεRIγGFP are captured by OT-I during trogocytosis 
triggered by antibodies. HEK cells transfected with a vector encoding murine flagged 
FcγRIIIA plus FcRγGFP were incubated with OT-I T cells coated (bottom panels) or not (top 
panels) with the anti-H-2Kb mAb. Cells were analyzed by flow cytometry using anti-CD8 
mAb and a biotinylated mAb against FcγRII/III followed by fluorescent streptavidin and by 
analyzing the GFP fluorescence. Note that HEK cells that were mock-transfected do not allow 
triggering of trogocytosis by OT-I T cells (not shown). 
 
Figure 2. HEK-FcγRIII/FcRγGFP and OT-I T cells can easily been distinguished on a 
morphological basis by electron microscopy. HEK cells transfected with FcγRIII and 
FcRγGFP and OT-I T cells were processed for electron microscopy analysis then analyzed at 
a low magnification.  
 
Figure 3. Localization of endogenously expressed FcRγGFP in HEK-FcγRIII/FcRγGFP 
cells. HEK cells transfected with FcγRIIIA and FcRγGFP were processed for electron 
microscopy analysis after staining with rabbit anti-GFP antiserum followed by anti-rabbit IgG 
coupled to gold particles. Arrowheads indicate representative structures showing immunogold 
labeling in HEK cells.  
 
Figure 4. Localization of acquired FcRγGFP  in OT-I T cells. OT-I T cells were incubated 
with HEK cells transfected with FcγRIIIA and FcRγGFP for 1-hour in the presence of the anti-
H-2Kb mAb in order to trigger trogocytosis. Cells were then processed for electron 
microscopy analysis after staining with rabbit anti-GFP antiserum followed by anti-rabbit IgG 
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coupled to gold particles. Arrowheads indicate representative structures showing immunogold 
labeling in OT-I T cells.  
 
Figure 5, 6 and 7. Localization of acquired FcRγGFP  at the area of contact between OT-I 
T cells and HEK transfectant. OT-I T cells were incubated with HEK cells transfected with 
FcγRIIIA and FcRγGFP for 1-hour in the presence of the anti-H-2Kb mAb in order to trigger 
trogocytosis. Cells were then processed for electron microscopy analysis after staining with 
rabbit anti-GFP antiserum followed by anti-rabbit IgG coupled to gold particles. The images 
are focused on the area of contact between T cells and HEK transfectants (right panels) that 
are presented at a lower magnification (left part of the images). 
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